Seres Therapeutics, Inc. (MCRB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Seres Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 23.14x | 949.54x | -1.58x | -2.42x | -11.65x | -21.93x |
| P/B Ratio | 2.98x | 9.37x | -4.00x | 56.13x | 5.81x | 11.19x |
| P/S Ratio | 167.07x | 0.00x | 0.00x | 0.00x | 5.27x | 58.85x |
| Profitability | ||||||
| Gross Margin | -423.8% | 0.0% | 0.0% | 0.0% | 100.0% | -172.7% |
| Operating Margin | -11910.1% | 0.0% | 0.0% | 0.0% | -44.5% | -265.3% |
| Net Margin | 721.9% | 0.0% | 0.0% | 0.0% | -45.2% | -268.3% |
| EBITDA Margin | -11386.3% | 0.0% | 0.0% | 0.0% | -39.1% | -232.8% |
| Liquidity | ||||||
| Current Ratio | 2.56x | 0.94x | 1.78x | 2.28x | 3.69x | 5.79x |
| Quick Ratio | 2.56x | 0.94x | 1.48x | 2.28x | 3.69x | 5.79x |
| Leverage | ||||||
| Debt/Equity | 1.88x | 6.65x | -4.43x | 15.08x | 0.37x | 0.23x |
YoY = year-over-year change. Source: FMP..